HKEX:2102 stock news
This page provides real-time market news, earnings updates, and company announcements related to Tak Lee Machinery Holdings Limited (HKEX:2102).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-26 08:03 HKT
India’s Web3 Breakthrough: IBW2025 Drives Aspirations to Become a Global Innovation Center
Bitget-RWA2025-11-19 14:40:18
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer
Finviz2026-02-19 21:04:00
Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston
Finviz2026-02-24 13:06:43
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-02-26 21:03:46
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment
Finviz2026-03-08 16:03:55
BK Technologies Announces Launch of LocateONE LITE
Finviz2026-03-11 12:06:09
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Finviz2026-03-17 12:09:49
Safe Pro Completes Latest U.S. Army Transforming in Contact 2.0 Exercise at Fort Hood, Texas
Finviz2026-03-17 12:06:54
Breakthrough in new drug development boosts market confidence: Ovid Therapeutics Inc. (NASDAQ: OVID) shares surged 26.4% in pre-market trading today after the company announced positive safety data for its experimental epilepsy drug OV935/TAK-935.
老虎证券2026-03-18 10:52:38
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance2026-02-27 15:09:40
FDA Grants Priority Review for Takeda (TAK) and Protagonist's Rusfertide in PV Treatment
Finviz2026-03-08 16:03:55
BK Technologies Announces Launch of LocateONE LITE
Finviz2026-03-11 12:06:09
Denali Rises 11.8% Over the Past Month: Should You Buy, Sell, or Keep the Stock?
101 finance2026-03-11 16:40:19
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Finviz2026-03-17 12:09:49
Safe Pro Completes Latest U.S. Army Transforming in Contact 2.0 Exercise at Fort Hood, Texas
Finviz2026-03-17 12:06:54
Breakthrough in new drug development boosts market confidence: Ovid Therapeutics Inc. (NASDAQ: OVID) shares surged 26.4% in pre-market trading today after the company announced positive safety data for its experimental epilepsy drug OV935/TAK-935.
老虎证券2026-03-18 10:52:38
HKEX:2102 stock price change
On the last trading day, HKEX:2102 stock closed at 0.32 HKD, with a price change of 3.28% for the day.
Trade stock perpsHKEX:2102 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more